These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25048468)

  • 1. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
    Lavery LA; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J;
    Int Wound J; 2014 Oct; 11(5):554-60. PubMed ID: 25048468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers.
    Farivar BS; Toursavadkohi S; Monahan TS; Sharma J; Ucuzian AA; Kundi R; Sarkar R; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):228-233. PubMed ID: 30621916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
    Pacaccio DJ; Cazzell SM; Halperin GJ; Kasper MA; Neutel JM; O'Carroll BD; Reyzelman AM
    J Wound Care; 2018 Jul; 27(Sup7):S28-S37. PubMed ID: 30008251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
    Zelen CM; Serena TE; Gould L; Le L; Carter MJ; Keller J; Li WW
    Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.
    Galiano R; Snyder R; Mayer P; Rogers LC; Alvarez O;
    J Wound Care; 2019 Jun; 28(6):383-395. PubMed ID: 31166864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial.
    Snyder R; Nouvong A; Ulloa J; Wahab N; Treadwell T; Bruwer F; Naude L; McGuire J; Reyzelman AM; Graham T; ; Lessing R; Lullove E; Ozker E; Pham HT; Pasternac M; Cohen S
    J Wound Care; 2024 Sep; 33(9):688-700. PubMed ID: 39287414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
    Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting.
    Raspovic KM; Wukich DK; Naiman DQ; Lavery LA; Kirsner RS; Kim PJ; Steinberg JS; Attinger CE; Danilkovitch A
    Wound Repair Regen; 2018 Mar; 26(2):213-220. PubMed ID: 29683538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label Extension Phase of a Chronic Diabetic Foot Ulcer Multicenter, Controlled, Randomized Clinical Trial Using Cryopreserved Placental Membrane.
    Lavery L; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J; Hesp Z
    Wounds; 2018 Sep; 30(9):283-289. PubMed ID: 30256747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM; Caporusso J; Vayser D; Davis RD; Alvarez OM; Sabolinski ML
    J Wound Care; 2024 Jul; 33(Sup7):S4-S14. PubMed ID: 38973638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
    Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
    Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic foot ulcer treatment with focused shockwave therapy: two multicentre, prospective, controlled, double-blinded, randomised phase III clinical trials.
    Snyder R; Galiano R; Mayer P; Rogers LC; Alvarez O;
    J Wound Care; 2018 Dec; 27(12):822-836. PubMed ID: 30557108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.